Dr. med. Thomas Brunk Gastroenterologie Berlin

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis5 trials
• Crohn's disease1 trial

Phase

• Phase 34 trials
• Phase 21 trial
• Phase 41 trial

Status

• Completed3 trials
• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• AbbVie2 trials
• Abivax S.A.2 trials
• Sanofi-Aventis Recherche & Developpement1 trial
• University Hospital Schleswig-Holstein1 trial

Running trials

• Recruiting

  Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis

  NCT07235904· Phase 4· University Hospital Schleswig-Holstein· Source

• Active, not recruiting

  ABTECT - Maintenance

  NCT05535946· Phase 3· Abivax S.A.· Source

• Active, not recruiting

  A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis

  NCT03398135· Phase 3· AbbVie· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ulcerative colitis1 recruiting

Closed trials

• Completed

  A study to investigate efficacy and safety of SAR441566 in patients with ulcerative colitis

  NCT06867094· Phase 2· Sanofi-Aventis Recherche & Developpement· Source

• Completed

  ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

  NCT05507203· Phase 3· Abivax S.A.· Source

• Active, not recruiting

  A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease

  NCT03105102· Phase 3· AbbVie· Source